These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6382203)

  • 1. [Results of ambulatory follow-up of patients after myocardial infarction treated with platelet aggregation inhibitors and antithrombotic drugs].
    Markiewicz M; Rymar B; Florkiewicz H; Wysokiński A
    Pol Tyg Lek; 1983 Nov; 38(48):1501-3. PubMed ID: 6382203
    [No Abstract]   [Full Text] [Related]  

  • 2. [Results of prevention of second myocardial infarct with syncumar or aspirin].
    Kraska T; Malanowicz W; Skarzyńska M; Tymińska K
    Kardiol Pol; 1981; 24(9):593-7. PubMed ID: 7029110
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiplatelet therapy and progression of coronary artery disease: a placebo-controlled trial with angiographic and clinical follow-up after myocardial infarction.
    Dieker HJ; French JK; Joziasse IC; Brouwer MA; Elliott J; West TM; Webber BJ; Verheugt FW; White HD
    Am Heart J; 2007 Jan; 153(1):66.e1-8. PubMed ID: 17174639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary study of effect of aspirin and dipyridamole on platelet adhesiveness and fibrinolytic activity in acute myocardial infarction.
    Jhawar BK; Trivedi HH; Bhargava RK; Misra NP
    J Assoc Physicians India; 1978 Sep; 26(9):805-9. PubMed ID: 370078
    [No Abstract]   [Full Text] [Related]  

  • 5. Persantine-aspirin reinfarction study. Design, methods and baseline results. By the persantine-aspirin reinfarction study research group.
    Circulation; 1980 Sep; 62(3 Pt 2):II1-42. PubMed ID: 7408140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study of 2 antithrombotic regimens in 75 patients with coronary endoprostheses].
    Iturbe T; Sánchez C; Moreno JA; Olave T; Azaceta G; Varo MJ; Civeira E; Peleato J; Cornudella R
    Sangre (Barc); 1997 Oct; 42(5):387-90. PubMed ID: 9424739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of platelet-active drugs in coronary artery disease.
    Sherry S
    Cardiovasc Clin; 1983; 14(1):173-89. PubMed ID: 6352025
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophes.
    Sherry S
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():173-210. PubMed ID: 6216782
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anticoagulants and thrombocyte aggregation inhibitors in or following myocardial infarct].
    Rühle H
    Z Arztl Fortbild (Jena); 1985; 79(11):463-6. PubMed ID: 3901541
    [No Abstract]   [Full Text] [Related]  

  • 10. Summary of ongoing clinical trials of platelet-active drugs in cardiovascular disease.
    Passamani ER
    Circulation; 1980 Dec; 62(6 Pt 2):V106-10. PubMed ID: 7002348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevention and treatment of recurrences of myocardial infarction. Results in 2026 patients monitored for 44 months in a group study].
    Sem Hop; 1980 Oct 18-25; 56(39-40):1575-7. PubMed ID: 6255571
    [No Abstract]   [Full Text] [Related]  

  • 12. Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells.
    Turpie AG
    Prog Clin Biol Res; 1982; 89():31-62. PubMed ID: 7051035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Secondary prevention of coronary disease with platelet aggregation inhibiting drugs. Preliminary report].
    Caruzzo C; Belli R; Biasci R; Gaschino G; Bruna C
    Minerva Cardioangiol; 1979 Jun; 27(6):367-72. PubMed ID: 38413
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of dipyridamole in patients with recent stroke or TIA.
    Bernstein RA
    Am Fam Physician; 2005 Aug; 72(3):382, 384; author reply 384. PubMed ID: 16100852
    [No Abstract]   [Full Text] [Related]  

  • 15. E.P.S.I.M., the French oral anticoagulant--aspirin trial in post-myocardial infarction patients: design, organization and quality control procedures.
    Boissel JP; Leizorovicz A; Schbath J; Destors JM; Gillet J
    Scand J Haematol Suppl; 1981; 38():47-72. PubMed ID: 7038857
    [No Abstract]   [Full Text] [Related]  

  • 16. Platelet aggregation and atherosclerosis.
    Valladares BK; Lemberg L
    Heart Lung; 1986 Mar; 15(2):211-4. PubMed ID: 3633253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral anticoagulant treatment with and without aspirin.
    Altman R; Rouvier J; Gurfinkel E
    Thromb Haemost; 1995 Jul; 74(1):506-10. PubMed ID: 8578514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of aspirin to prevent myocardial infarction and adverse outcome during follow-up - a large series of all-comers.
    Mikkelsson J; Eskola M; Nikus K; Karhunen PJ; Niemela K
    Ann Med; 2008; 40(4):296-302. PubMed ID: 18428022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Persantin and aspirin in coronary heart disease. The persantin-aspirin reinfarction study group (PARIS)].
    MMW Munch Med Wochenschr; 1980 Dec; 122(49):1761-71. PubMed ID: 6779148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does dipyridamole have antithrombotic potential?
    Loeliger EA
    Thromb Haemost; 1985 Jun; 53(3):437. PubMed ID: 4049315
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.